(Q83967267)
Statements
Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network (English)
B S Kahl
W L Longo
J C Eickhoff
J Zehnder
C Jones
J Blank
T McFarland
W Bottner
H Rezazedeh
J Werndli
H H Bailey
Wisconsin Oncology Network